Provided by Tiger Trade Technology Pte. Ltd.

Insulet

242.74
+1.920.80%
Post-market: 242.50-0.2400-0.10%16:54 EST
Volume:776.05K
Turnover:190.05M
Market Cap:17.08B
PE:70.34
High:249.73
Open:241.63
Low:241.63
Close:240.82
52wk High:354.88
52wk Low:230.05
Shares:70.35M
Float Shares:70.08M
Volume Ratio:0.79
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.45
EPS(LYR):5.78
ROE:19.68%
ROA:8.74%
PB:12.34
PE(LYR):41.97

Loading ...

Earning Preview: Insulet revenue is expected to increase by 31.89% this quarter, and institutional views are predominantly bullish

Earnings Agent
·
Feb 11

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 13

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 10

BTIG Keeps Their Buy Rating on Insulet (PODD)

TIPRANKS
·
Feb 05

Insulet bringt Omnipod 5 und Omnipod Discover in den Nahen Osten

Reuters
·
Feb 05

Stifel Adjusts Price Target on Insulet to $350 From $370, Maintains Buy Rating

MT Newswires Live
·
Feb 05

Insulet Extends Key Supply Agreement with NXP USA

TIPRANKS
·
Feb 04

Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 04

Insulet Corporation verlängert Liefervertrag mit NXP USA

Reuters
·
Feb 04

Insulet’s Omnipod M Study Completes Key Milestone in Type 2 Diabetes Onboarding

TIPRANKS
·
Jan 31

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jan 28

Insulet Corp. Stock Slides 3.0%, Underperforms Peers

Dow Jones
·
Jan 24

Insulet Completes Key Omnipod 5 SmartAdjust 2.0 Study, Setting Up Next Growth Phase

TIPRANKS
·
Jan 23

Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Gilead Sciences (GILD)

TIPRANKS
·
Jan 22

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jan 21

Goldman Sachs Adjusts Price Target on Insulet to $363 From $365, Maintains Buy Rating

MT Newswires Live
·
Jan 16

Insulet Corporation highlights diabetes management leadership and market growth in new investor presentation

Reuters
·
Jan 14

Insulet (PODD) Receives a Buy from Bernstein

TIPRANKS
·
Jan 14

Wells Fargo Sticks to Their Buy Rating for Insulet (PODD)

TIPRANKS
·
Jan 13

Insulet Corp. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Jan 13